| Brand name |
Rivaroxaban QO
|
|---|---|
| المخاطر |
Bleeding during treatment with Rivaroxaban including the following information: Dosing recommendations, Oral intake, Perioperative management, Contraindications, Overdose, How to manage bleeding complications, and Coagulation testing. |
| تاريخ الموافقة |
|
| Educational materials for healthcare practitioners | |
| المواد التعليمية الموجهة للمريض |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Thu 25 Jun 2026
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Government websites use the protocol. HTTPS for encryption and security.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.